In-Vitro Diagnostic Market Size, Segments, and Trends by 2030
In-Vitro Diagnostic Market: Strategic Insights
In-Vitro Diagnostic Market
-
CAGR (2022 - 2030)5.6% -
Market Size 2022
US$ 72.39 Billion -
Market Size 2030
US$ 112.1 Billion
Market Dynamics
GROWTH DRIVERS
- Rising incidence of chronic diseases
- Demand for early diagnostic tools
FUTURE TRENDS
- Adoption of molecular diagnostics
- Advancements in lab automation
OPPORTUNITIES
- Growth in point-of-care diagnostic testing
- Expansion into emerging healthcare markets
Key Players
- Abbott Laboratories
- F Hoffmann La Roche Ltd
- Danaher Corp
- Siemens AG
- Sysmex Corp
- Thermo Fisher Scientific Inc
- Becton Dickinson and Co
- bioMerieux SA
- Bio Rad Laboratories Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product & Service
- Reagents & Kits
- Instruments
- Software & Services
Technology
- Immunoassay/ Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Blood Glucose Self-Monitoring
- Coagulation and Hemostasis
- Hematology
- Urinalysis
Application
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Autoimmune Diseases
- Nephrology
End User
- Hospitals
- Laboratories
- Home Care